346 related articles for article (PubMed ID: 29998578)
1. Salivary S100A8/A9 in Sjögren's syndrome accompanied by lymphoma.
Jazzar AA; Shirlaw PJ; Carpenter GH; Challacombe SJ; Proctor GB
J Oral Pathol Med; 2018 Oct; 47(9):900-906. PubMed ID: 29998578
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of ultrasound scoring in relation to clinical and histological parameters in xerostomia patients.
Jazzar A; Manoharan A; Brown JE; Shirlaw PJ; Carpenter GH; Challacombe SJ; Proctor GB
Oral Dis; 2019 Jan; 25(1):150-157. PubMed ID: 30120806
[TBL] [Abstract][Full Text] [Related]
3. Investigation of three potential autoantibodies in Sjogren's syndrome and associated MALT lymphoma.
Cui L; Elzakra N; Xu S; Xiao GG; Yang Y; Hu S
Oncotarget; 2017 May; 8(18):30039-30049. PubMed ID: 28404907
[TBL] [Abstract][Full Text] [Related]
4. Proteomic and histopathological characterisation of sicca subjects and primary Sjögren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers.
Aqrawi LA; Galtung HK; Guerreiro EM; Øvstebø R; Thiede B; Utheim TP; Chen X; Utheim ØA; Palm Ø; Skarstein K; Jensen JL
Arthritis Res Ther; 2019 Jul; 21(1):181. PubMed ID: 31366407
[TBL] [Abstract][Full Text] [Related]
5. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
Beckman KA; Luchs J; Milner MS; Ambrus JL
Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
[TBL] [Abstract][Full Text] [Related]
6. FcRL4
Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
[TBL] [Abstract][Full Text] [Related]
7. [Development of MALT-lymphoma in Sjögren syndrome].
Vissink A; van der Meij EH; Spijkervet FKL
Ned Tijdschr Tandheelkd; 2020 Oct; 127(10):543-550. PubMed ID: 33156295
[TBL] [Abstract][Full Text] [Related]
8. Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis.
Ryu OH; Atkinson JC; Hoehn GT; Illei GG; Hart TC
Rheumatology (Oxford); 2006 Sep; 45(9):1077-86. PubMed ID: 16522680
[TBL] [Abstract][Full Text] [Related]
9. B cell MALT lymphoma diagnosed by labial minor salivary gland biopsy in patients screened for Sjögren's syndrome.
Van Mello NM; Pillemer SR; Tak PP; Sankar V
Ann Rheum Dis; 2005 Mar; 64(3):471-3. PubMed ID: 15708896
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type.
Fabris M; Dolcetti R; Pasini E; Quartuccio L; Pontarini E; Salvin S; Ponzoni M; Scott CA; De Vita S
Clin Exp Rheumatol; 2014; 32(1):61-5. PubMed ID: 24447326
[TBL] [Abstract][Full Text] [Related]
11. The status of lactoferrin and total iron binding capacity of human parotid saliva in Sjögren's syndrome.
Haghighat N; al-Hashimi I
Clin Exp Rheumatol; 2003; 21(4):485-8. PubMed ID: 12942702
[TBL] [Abstract][Full Text] [Related]
12. Clinical, histopathological and immunohistological study of lymphoid disorders in the parotid gland of patients with Sjögren's syndrome.
Bozinović MT; Katić V; Krasić D; Veselinović D; Jovanović P; Krstić M
Vojnosanit Pregl; 2009 Dec; 66(12):955-60. PubMed ID: 20095514
[TBL] [Abstract][Full Text] [Related]
13. Phagocyte-specific S100A8/A9 is upregulated in primary Sjögren's syndrome and triggers the secretion of pro-inflammatory cytokines in vitro.
Nicaise C; Weichselbaum L; Schandene L; Gangji V; Dehavay F; Bouchat J; Balau B; Vogl T; Soyfoo MS
Clin Exp Rheumatol; 2017; 35(1):129-136. PubMed ID: 27749214
[TBL] [Abstract][Full Text] [Related]
14. Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren's syndrome: a retrospective clinical study.
Pollard RP; Pijpe J; Bootsma H; Spijkervet FK; Kluin PM; Roodenburg JL; Kallenberg CG; Vissink A; van Imhoff GW
J Rheumatol; 2011 Oct; 38(10):2198-208. PubMed ID: 21844152
[TBL] [Abstract][Full Text] [Related]
15. [MALT-type parotid lymphoma--a case report and the review of the literature].
Wierzbicka M; Bartochowska A; Kopeć T; Szyfter W
Otolaryngol Pol; 2013; 67(1):61-5. PubMed ID: 23374667
[TBL] [Abstract][Full Text] [Related]
16. The P2X7 receptor-NLRP3 inflammasome complex predicts the development of non-Hodgkin's lymphoma in Sjogren's syndrome: a prospective, observational, single-centre study.
Baldini C; Santini E; Rossi C; Donati V; Solini A
J Intern Med; 2017 Aug; 282(2):175-186. PubMed ID: 28503820
[TBL] [Abstract][Full Text] [Related]
17. Sialometry and sialochemistry: diagnostic tools for Sjögren's syndrome.
Kalk WW; Vissink A; Spijkervet FK; Bootsma H; Kallenberg CG; Nieuw Amerongen AV
Ann Rheum Dis; 2001 Dec; 60(12):1110-6. PubMed ID: 11709452
[TBL] [Abstract][Full Text] [Related]
18. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes.
Baldini C; Giusti L; Ciregia F; Da Valle Y; Giacomelli C; Donadio E; Sernissi F; Bazzichi L; Giannaccini G; Bombardieri S; Lucacchini A
Arthritis Res Ther; 2011; 13(6):R194. PubMed ID: 22117835
[TBL] [Abstract][Full Text] [Related]
20. A biomarker for lymphoma development in Sjogren's syndrome: Salivary gland focus score.
Chatzis L; Goules AV; Pezoulas V; Baldini C; Gandolfo S; Skopouli FN; Exarchos TP; Kapsogeorgou EK; Donati V; Voulgari PV; Mavragani CP; Gorgoulis V; De Vita S; Fotiadis D; Voulgarelis M; Moutsopoulos HM; Tzioufas AG
J Autoimmun; 2021 Jul; 121():102648. PubMed ID: 34029875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
